Vasundhara Rasayans Limited (BOM:538634)
158.35
+9.45 (6.35%)
At close: Jun 1, 2026
Vasundhara Rasayans Revenue
In the fiscal year ending March 31, 2026, Vasundhara Rasayans had annual revenue of 386.27M INR with 13.64% growth. Vasundhara Rasayans had revenue of 125.84M in the quarter ending March 31, 2026, with 62.24% growth.
Revenue
386.27M
Revenue Growth
+13.64%
P/S Ratio
1.30
Revenue / Employee
11.71M
Employees
33
Market Cap
503.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 386.27M | 46.37M | 13.64% |
| Mar 31, 2025 | 339.90M | -30.28M | -8.18% |
| Mar 31, 2024 | 370.18M | -9.23M | -2.43% |
| Mar 31, 2023 | 379.41M | 111.91M | 41.83% |
| Mar 31, 2022 | 267.50M | 40.71M | 17.95% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Kimia Biosciences | 1.17B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 918.89M |
| Tyche Industries | 628.56M |
| Crestchem | 266.14M |
| Krebs Biochemicals & Industries | 237.32M |
| Ishita Drugs and Industries | 161.68M |